Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Tazemetostat in Combination With CHOP for Previously Untreated T Cell Lymphoma

NCT06692452 is registered in ClinicalTrials.gov with Eric Jacobsen, MD as lead sponsor.

NCT NCT06692452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06692452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Tazemetostat in Combination With CHOP for Previously Untreated T Cell Lymphoma
Lead sponsor
Eric Jacobsen, MD
Phase
Phase 2
Overall status
Withdrawn
Start date
December 24, 2024
Completion date
October 1, 2032
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

angioimmunoblastic t-cell lymphoma, enteropathy-associated t-cell lymphoma, lymphoma, monomorphic epitheliotropic intestinal t-cell lymphoma, peripheral t cell lymphoma